The impact of metabolic syndrome on hepatocellular carcinoma: a mendelian randomization study
Abstract Traditional epidemiological studies are susceptible to confounding factors. To clarify the impact of metabolic syndrome and its diagnostic components on hepatocellular carcinoma, we conducted a preliminary mendelian randomization analysis with metabolic syndrome and its diagnostic component...
Saved in:
Main Authors: | Chendong Yuan, Xufeng Shu, Xiaoqiang Wang, Wenzheng Chen, Xin Li, Wenguang Pei, Xujie Su, Zhenzhen Hu, Zhigang Jie |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86317-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutual causal effects between immune cells and hepatocellular carcinoma: a Mendelian randomization study
by: Zheng Wang, et al.
Published: (2025-01-01) -
Genetic Determinants of Immune Cells and Hepatocellular Carcinoma Risk: A Bioinformatics and Bidirectional Mendelian Randomization Study
by: Tong WU, et al.
Published: (2025-01-01) -
Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
by: Rafat Shadmehr, et al.
Published: (2025-01-01) -
Investigating the correlation of hip circumference to cardiovascular disease and type‐2 diabetes using Mendelian randomization
by: Hongtao Liu, et al.
Published: (2025-02-01) -
Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
by: Jianyan Pan, et al.
Published: (2025-02-01)